Physician profile
Ami D Acharya
NPI 1437131760
$1,856.66
in general payments reported to CMS, 2019-2025
8 companies · $20.67 in 2025
The $20.67 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.65 · 2020: $51.99 · 2021: $131 · 2023: $1,500 · 2024: $97.04 · 2025: $20.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $117.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $1,500.00 | 2023 | Desara |
| Novo Nordisk INC | $120.00 | 2021 | |
| Applied Medical Resources Corporation | $72.19 | 2024 | Gelpoint V-Path |
| Astellas Pharma US INC | $70.57 | 2019-2020 | |
| Abbvie INC. | $26.40 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $24.85 | 2024 | |
| Allergan, INC. | $21.98 | 2019 | |
| Hologic Sales and Service, LLC | $20.67 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami Acharya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.